Publicaciones en las que colabora con C. Villanueva Bueno (15)

2023

  1. Complementary and alternative medicine in cancer patients: characteristics of use and interactions with antineoplastic agents

    Journal of Cancer Research and Clinical Oncology, Vol. 149, Núm. 7, pp. 2855-2882

  2. Medication guide for dose adjustment and management of cardiotoxicity and lipid metabolic adverse events of oral antineoplastic therapy

    Frontiers in Oncology, Vol. 13

  3. Possible heart failure caused by osimertinib in a lung cancer patient

    Journal of Oncology Pharmacy Practice, Vol. 29, Núm. 4, pp. 1015-1020

2022

  1. A smartphone app to improve the safety of patients undergoing treatment with oral antineoplastic agents: 4 years of experience in a university hospital

    Frontiers in Public Health, Vol. 10

  2. Implantación de una metodología para evaluar patient‑reported outcomes en pacientes con cáncer de pulmón: Protocolo del estudio PeOpLe (Patient‑reported Outcomes in Lung cancer )

    Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria, Vol. 46, Núm. 4, pp. 265-269

  3. Implementation and evaluation of a home pharmaceutical care model through Telepharmacy

    Farmacia Hospitalaria, Vol. 46, pp. 36-46

  4. Medication guide for the perioperative management of oral antineoplastic agents in cancer patients

    Expert Opinion on Drug Safety, Vol. 21, Núm. 1, pp. 107-119

  5. Mobile Apps for Hematological Conditions: Review and Content Analysis Using the Mobile App Rating Scale

    JMIR mHealth and uHealth, Vol. 10, Núm. 2

  6. Patient-reported outcomes y aplicaciones móviles. Revisión de su impacto en los resultados en salud de los pacientes

    Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria, Vol. 46, Núm. 3, pp. 173-181

  7. Potential negative pharmacodynamic interaction of spironolactone and abiraterone in two prostate cancer patients

    Journal of Oncology Pharmacy Practice, Vol. 28, Núm. 5, pp. 1259-1263

  8. Smartphone-Based Ecological Momentary Assessment for the Measurement of the Performance Status and Health-Related Quality of Life in Cancer Patients Under Systemic Anticancer Therapies: Development and Acceptability of a Mobile App

    Frontiers in Oncology, Vol. 12

2021

  1. Acute pancreatitis in a patient treated with imatinib and gefitinib

    Journal of Oncology Pharmacy Practice, Vol. 27, Núm. 4, pp. 980-983

  2. COVID-19 in hospitalised patients in Spain: a cohort study in Madrid

    International Journal of Antimicrobial Agents, Vol. 57, Núm. 2

  3. Potential and real drug interactions in patients treated with abiraterone or enzalutamide in clinical practice

    Expert Opinion on Drug Metabolism and Toxicology, Vol. 17, Núm. 12, pp. 1467-1473

2020

  1. Features and functionalities of smartphone apps related to COVID-19: Systematic search in app stores and content analysis

    Journal of Medical Internet Research, Vol. 22, Núm. 8